HEALTH OF WOMAN. 2019.3(139): 25–30; doi 10.15574/HW.2019.139.25

Silina N. K., Koval H. M., Titova T. A., Pogorila O. I., Silina T. M.
SI «Institute of Pediatrics, Obstetrics and Gynecology named after academician O.M. Lukyanova NAMS of Ukraine», Kiev
SHEE «Uzhhorod National University»
Shupyk National Medical Academy of Postgraduate Education, Kiev

The objective: study of clinical and social aspects of teenage girls’ health, detection of vulvovaginal infections and their complex treatment with doramycin and the prevention of vaginal dysbiosis by brevelac.

Materials and methods. In this work, anamnestic, general clinical-statistical and modern methods of microbiological examination such as the vaginal test “citolab” were used to determine the pH of the vagina environment. On this basis vulvovaginitis diagnosed in 56 surveyed teen girls 16–18 years who have had sexual relations. Based on the diagnosis criteria have been taken according to the European guidelines for the management of patients with vaginal pathologies (2011 European (IUSTI / WHO) Guideline on the Management of Vaginal Diascharge). All patients had a complex treatment by antibacterial drugs Doramitsyn according the scheme and for the prevention of vagina dysbiosis Brevelak has been applied. Quality control was performed at 30 and 90 days after discontinuation of therapy.

Results. The sexual behavior of young people in Ukraine has changed dramatically over the past decades with a more risky and overwhelming attitude towards sexual issues. The average age of the first sexual contact among teenage girls is an average of 15.1 years. And this actualizes the problem of sexually transmitted infections, their early detection and timely treatment. We conducted an analysis of the dynamics of anamnestic, clinical and laboratory indicators in teen girls aged 16–18 years with vulvovaginitis treated with antibacterial drug Doramycin with the prevention of vaginal dysbiosis with Brevelak. In patients of the study group, the treatment was effective with a rapid onset of positive results with a complete clinical response in 91.1% of cases, with the restoration of the microflora and pH of the vaginal medium (M±m) 4.3±0.2 (at normal pH <4, 5) and with no recurrence after 30 and 90 days after treatment.

Conclusion. Changing the sexual behavior of young people argued the need for information company to be conducted for teens and their families with the aim of early detection and effective treatment of sexually transmitted infections. An integrated approach in the treatment of vulvovaginitis in teenage girls with antibacterial drug Doramycin and probiotic Brevelac is effective in 91.1% cases of applied therapy.

Key words: teenage girls, vulvovaginitis, treatment, Doramycin, Brevelak.

REFERENCES

1. Anfilova MR. 2012. Sotsialnyi portret suchasnoho pidlitka iz zakhvoriuvanniamy, shcho peredaiutsia statevym shliakhom. Ukrainskyi zhurnal dermatolohii, venerolohii ta kosmetologii 3 (46): 44–47.

2. Astakhov VM., Marvan Ausci. 2013. Suchasni pohliady na mikroekosystemu pikhvy. Zh. «Medyko-sotsyalnye problemy semy» 18;1: 113–115.

3. Beniuk VO, Shcherba OA. 2013. Osoblyvosti funktsionalnoho stanu slyzovoi obolonky pikhvy ta shyiky matky za umov mikst-infektsii. Zdorove zhenshchіnу 3 (79):71–75.

4. Grischenko OV, Kozub TA. 2017. Novyie podhodyi v kompleksnoy terapii vospalitelnyih zabolevaniy organov malogo taza u zhenschin reproduktivnogo vozrasta. Zdorove zhenschiny 2 (118): 41–44.

5. Kononova IN, Oboskalov TA. 2015. Personalizirovannyiy podhod k korrektsii biotsenoza vlagalischa. Ginekologiya 02: 17–20.

6. Klinichne vedennia patsiientok zi skarhamy na patolohichni vahinalni vydilennia mizhnarodni rekomendatsii Korolivskoho koledzhu akusherstva i hinekolohii Velykobrytanii i Brytanskoi asotsiatsii seksualnoho zdorovia i VIL (2012 r.). Zhinochyi likar 2: 48–54. 2013.

7. Lahno IV, Grischenko OV. 2016. Stupenchataya terapiya vaginalnogo disbioza: mozaika dokazatelstv. Reproduktivna endokrinologiya 2 (28): 58–59. K.

8. Podolskiy VlV. 2013. Kliniko-epidemiologicheskaya harakteristika zhenschin fertilnogo vozrasta s hronicheskimi vospalitelnyimi zabolevaniyami polovyih organov. Akusherstvo i ginekologiya 4: 61–66.

9. Podolskyi VlV, Podolskyi VV, Fedorych PV. 2018. Optymizatsiia likuvannia khronichnykh zapalnykh zakhvoriuvan statevykh orhaniv u zhinok fertylnoho viku z urakhuvanniam mizhnarodnoho dosvidu: metodychni rekomendatsii (№ 94/2017):12. K.

10. Fedorych PV, Prymak AV, Konovalova TS. 2013. Bakterialnyi vahinoz: suchasnyi pohliad na problemu. Ratsionalna terapiia ta reabilitatsiini zakhody shchodo sposobu zhyttia patsiientok. Ukrainskyi zhurnal dermatologii, venerologii, kosmetologii 3 (50):86–94.

11. Yakubovskyi DS, Shyrobokov VP, Antypkyn YuH, Tatarchuk TF, Dyment HS. 2015.  Mykrobyom y zdorove zhenshchyny. Reproduktyvna endokrynologiia. Almanakh reproduktyvnoho zdorovia: 26–48. K.

12. Zozaya M, Ferris MJ, Siren JD et al. 2016. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome. 4; 6:161–166. https://doi.org/10.1186/s40168-016-0161-6.

13. Woods JL, Scurlock AM, Hensel DJ. 2013, Jun. Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider. Pediatr Emerg Care 29 (6):7 20-5. https://doi.org/10.1097/PEC.0b013e318294dd7b.

14. Dalhoff A. 2012, Jun. Resistance surveillance studies: a multifaceted problem–the fluoroquinolone example. Infection 40 (3): 239-62. https://doi.org/10.1007/s15010-012-0257-2. Epub 2012, Mar 30.